Stock A326030 SK BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company SK Biopharmaceuticals Co., Ltd.

Equities

A326030

KR7326030004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
82,700 KRW -2.01% Intraday chart for SK Biopharmaceuticals Co., Ltd. -5.92% -17.63%
Jan. 30 SK Biopharmaceuticals Swings to Profit in Q4 MT
2023 SK Group Advances Net Zero Transition via Key Renewable Energy Deal MT

Business Summary

SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.

Number of employees: 252

Sales per Business

KRW in Million2022Weight2023Weight Delta
New Drug Development
100.0 %
246,179 100.0 % 354,892 100.0 % +44.16%

Sales per region

KRW in Million2022Weight2023Weight Delta
United States
143.4 %
388,212 157.7 % 508,889 143.4 % +31.09%
Consolidated Adjustment
-130.9 %
-356,974 -145.0 % -464,702 -130.9 % +30.18%
South Korea
87.5 %
214,941 87.3 % 310,705 87.5 % +44.55%

Managers

Managers TitleAgeSince
Dong-Hoon Lee CEO
 Chief Executive Officer 56 22-12-31
Choi Jonggil PRN
 Corporate Officer/Principal - 22-12-31
Jeong-Woo Jo PRN
 Corporate Officer/Principal - 17-03-15

Members of the board

Members of the board TitleAgeSince
Geun-Joo Hwang BRD
 Director/Board Member 60 17-03-15
Jeong-Woo Jo PRN
 Corporate Officer/Principal - 17-03-15
Young-Ju Bang BRD
 Director/Board Member - 19-08-26
Hae-Young Ahn BRD
 Director/Board Member - 19-08-26
Min-Seop Song BRD
 Director/Board Member 54 19-08-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,313,250 27,996,731 ( 35.75 %) 0 35.75 %

Shareholders

NameEquities%Valuation
SK INC.
64.02 %
50,134,940 64.02 % 3 415 M ₩
Sjunde AP-fonden
0.0796 %
62,365 0.0796 % 4 M ₩
State Street Global Advisors Ltd.
0.0675 %
52,886 0.0675 % 4 M ₩
Northern Trust Fund Managers (Ireland) Ltd.
0.0341 %
26,716 0.0341 % 2 M ₩
Mercer Global Investments Europe Ltd.
0.0265 %
20,779 0.0265 % 1 M ₩
Guardians of New Zealand Superannuation
0.0253 %
19,817 0.0253 % 1 M ₩
Korea Investment Management Co., Ltd.
0.0185 %
14,467 0.0185 % 985 422 ₩
Storebrand Asset Management AS
0.0158 %
12,350 0.0158 % 841 222 ₩
Ji-young Jeong
0.0140 %
11,000 0.0140 % 749 266 ₩
Swedbank Robur Fonder AB
0.0134 %
10,497 0.0134 % 715 005 ₩

Company contact information

SK Biopharmaceuticals Co., Ltd.

221 Pangyoyeok-ro Bundang-gu

13494, Seongnam-si

+

http://www.skbp.com
address SK Biopharmaceuticals Co., Ltd.(A326030)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per region

Ratings for SK Biopharmaceuticals Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
82,700 KRW
Average target price
106,133 KRW
Spread / Average Target
+28.34%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-17.63% 4.8B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.08% 9.12B
YUHAN CORPORATION Stock Yuhan Corporation
+0.73% 3.8B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+16.55% 3.72B
INDIVIOR PLC Stock Indivior PLC
+27.76% 2.58B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-26.11% 2.36B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-30.09% 2.11B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+7.15% 1.86B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+1.45% 1.58B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A326030 Stock
  4. Company SK Biopharmaceuticals Co., Ltd.